Literature DB >> 10357207

Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment.

F L Dumoulin1, M Altfeld, J K Rockstroh, L Leifeld, T Sauerbruch, U Spengler.   

Abstract

Chemokines are a group of inducible, locally acting proinflammatory cytokines which have been implicated in the pathogenesis of a variety of diseases. Important members of the group include monocyte chemoattractant protein (MCP)-1, -2, -3, macrophage inhibitory protein (MIP)-1alpha, -1beta and RANTES (regulated upon activation, normal T expressed and secreted). To facilitate further investigation of the human chemokines, we have constructed a novel multispecific competitor fragment containing primer binding sites for the CC-chemokines MCP-1, MCP-2, MCP-3, MIP-1alpha, MIP-1beta and RANTES, the CXC-chemokines MIP-2alpha, MIP-2beta as well as for the housekeeping gene beta-actin. Using this competitor fragment we can demonstrate reliable semiquantitation of reverse transcribed chemokine mRNAs. The assay should be useful for further studies, in particular for the semiquantitation of chemokine mRNA species from small cell or tissue specimens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357207     DOI: 10.1016/s0022-1759(99)00009-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.

Authors:  Hans Dieter Nischalke; Jacob Nattermann; Hans-Peter Fischer; Tilman Sauerbruch; Ulrich Spengler; Franz Ludwig Dumoulin
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

2.  Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.

Authors:  I Vande Broek; K Asosingh; K Vanderkerken; N Straetmans; B Van Camp; I Van Riet
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.